참고문헌
- Cleeland CS. Cancer-related symptoms. Semin Radiat Oncol 2000; 10:175-90. https://doi.org/10.1053/srao.2000.6590
- Bruera E, Sala R, Rico MA, Moyano J, Centeno C, Willey J, et al. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. J Clin Oncol 2005;23:2366-71. https://doi.org/10.1200/JCO.2005.04.069
- Mercadante S, Ferrera P, Girelli D, Casuccio A. Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage 2005;30:354-8. https://doi.org/10.1016/j.jpainsymman.2005.04.004
- Lam S, Scannell R, Roessler D, Smith MA. Peripherally inserted central catheters in an acute-care hospital. Arch Intern Med 1994;154:1833-7. https://doi.org/10.1001/archinte.1994.00420160070009
- Ng PK, Ault MJ, Ellrodt AG, Maldonado L. Peripherally inserted central catheters in general medicine. Mayo Clin Proc 1997; 72:225-33. https://doi.org/10.4065/72.3.225
- Gunst M, Matsushima K, Vanek S, Gunst R, Shafi S, Frankel H. Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units. Surg Infect (Larchmt) 2011;12:279-82. https://doi.org/10.1089/sur.2008.058
- Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J, et al. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993;153:1791-6. https://doi.org/10.1001/archinte.1993.00410150073007
- Smith JR, Friedell ML, Cheatham ML, Martin SP, Cohen MJ, Horowitz JD. Peripherally inserted central catheters revisited. Am J Surg 1998;176:208-11. https://doi.org/10.1016/S0002-9610(98)00121-4
- Kim HJ, Yun J, Kim HJ, Kim KH, Kim SH, Lee SC, et al. Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study. J Korean Med Sci 2010;25:1748-53. https://doi.org/10.3346/jkms.2010.25.12.1748
- Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S. Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 2001;22: 997-1006. https://doi.org/10.1016/S0885-3924(01)00360-8
- Yamada R, Morita T, Yashiro E, Otani H, Amano K, Tei Y, et al. Patient-reported usefulness of peripherally inserted central venous catheters in terminally ill cancer patients. J Pain Symptom Manage 2010;40:60-6. https://doi.org/10.1016/j.jpainsymman.2009.11.327
- Kim EJ, Kim HJ, Kim HJ, Kim KH, Kim SH, Lee SC, et al. Retrospective analysis for complications of the central venous catheter in patients with cancer at a single center in Korea. Korean J Hosp Palliat Care 2010;13:24-31.
- Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, et al. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 2013;31:111-8. https://doi.org/10.1200/JCO.2012.44.6518
- Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol 2004;2:467-79, 83.
- McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003;348:1123-33. https://doi.org/10.1056/NEJMra011883
- Cheong K, Perry D, Karapetis C, Koczwara B. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours. Intern Med J 2004;34: 234-8. https://doi.org/10.1111/j.1444-0903.2004.00447.x
- Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 2002;20:3276-81. https://doi.org/10.1200/JCO.2002.11.135
- Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care (Engl) 2006;15:342-7. https://doi.org/10.1111/j.1365-2354.2006.00664.x
- Young A, Chapman O, Connor C, Poole C, Rose P, Kakkar AK. Thrombosis and cancer. Nat Rev Clin Oncol 2012;9:437-49. https://doi.org/10.1038/nrclinonc.2012.106
- Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009;373:567-74. https://doi.org/10.1016/S0140-6736(09)60205-1
- Lavau-Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Venat-Bouvet L, et al. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Cancer Chemother Pharmacol 2013;72:65-73. https://doi.org/10.1007/s00280-013-2169-y
- Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-15. https://doi.org/10.1001/archinte.160.6.809
피인용 문헌
- Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study vol.24, pp.12, 2016, https://doi.org/10.1007/s00520-016-3360-6
- Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study vol.53, pp.3, 2014, https://doi.org/10.4143/crt.2020.1008